Plumbagin as a mutli-target drug in treatment of cancer: A review

Abstract

Cancer is the fastest growing disease and leading cause of death in the world. Several drugs are available for the treatment of cancer with their merits and demerits, but not a single molecule is available which claims to cure cancer completely. Plumbagin (PL) is a napthoquinone derivative which is obtained as secondary metabolite from plumbago plant family, plumbaginaceae. Plambago plants are the flowering plants naturally occurring in Asia, Plumbago zeylanica specially found in India. Previously it was known as “chitraka” (in Ayurveda) whose root extracts were used for the treatment of dyspepsias, piles and diarrhoea. PL found to arrest the cell proliferation, metastasis and growth in various in-vitro and in-vivo studies Several researchers showed that PL modulates cytokines like interleukins, nuclear factor kappa B (NF-kB), tumour necrosis factor alpha (TNF-α), reactive oxygen species (ROS), phosphatidyl-inositol 3 kinase (PI3K) & p38 mitogen-activated protein kinase (MAPK), DNA degradation, jun n-terminal kinase (JNK), protien kinase-C (PKc), mechanistic target of rapamycin (mTOR) and signal transducers and activators of transcription (STAT) which are key player in the growth and development of normal cell at molecular level. PL found to arrest rapidly dividing cells, due to these features and activities, PL can be used in treatment of different kinds of cancers. This article provides an overview on the anti-cancer mechanism and speciality of a single agent PL, as a multi-target molecule obtained from plumbaginous plant in treatment of various types of cancer.

Authors and Affiliations

Prashant N. Amale, Shilpa A. Deshpande

Keywords

Related Articles

Acute antidepressant activity of ciprofloxacin and levofloxacin by using tail suspension test in swiss albino mice

Introduction Depression is a psychological disorder of serious nature characterized by loss of interest in all most all the activities of life In spite of many drugs available in the market yet their is still search for...

Proton pump inhibitor use and its relation to serum magnesium levels among hemodialysis patients: A single centre study in a South Indian tertiary care hospital

Introduction Proton pump inhibitors PPI are commonly used in clinical practice for various indications such as gastritis peptic ulcer and gastroesophageal reflux disease In Observational studies Hypomagnesaemia has been...

Patient-provider relationship: Compliance with care

The ProviderPatient Relationship PPR is a clever thought of restorative human science in which patients deliberately approach a master and along these lines transform into a bit of an assertion in which they will all in...

Improvement in lipid profile of the patients with saxagliptin as add on therapy to metformin in patients of type 2 DM who were previously on metformin alone with uncontrolled diabetes

Introduction Diabetes is characterized by chronic hyperglycemia and disturbances of carbohydrate lipid and protein metabolism This study is an attempt to show an improvement in lipid profile TC TG LDL and HDL in patients...

Importance of medication adherence and factors affecting it

Nonadherence leads to considerable morbidity mortality and avoidable health care costs adherence averages to only 50 in patients suffering from chronic medical illness Often adherence and compliance are used interchange...

Download PDF file
  • EP ID EP319020
  • DOI -
  • Views 110
  • Downloads 0

How To Cite

Prashant N. Amale, Shilpa A. Deshpande (2017). Plumbagin as a mutli-target drug in treatment of cancer: A review. IP International Journal of Comprehensive and Advanced Pharmacology, 2(1), 30-37. https://europub.co.uk./articles/-A-319020